Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA in CAD
Clinical trial NCT03284229 · COMPLETED
Trial details
- NCT number
- NCT03284229
- Sponsor
- Spectranetics Corporation
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-20
- Primary completion
- 2018-05-21
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.